Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
About the SELECT trial and SCORE real-world study: SELECT was a randomised, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of Wegovy (semaglutide 2.4 mg) versus placebo as an adjunct to standard of care for the prevention of MACE in people with overweight or obesity and established CVD with no prior history of diabetes
HSA and FSA eligibility Compounded tirzepatide prescribed by a licensed physician for a qualifying medical condition is generally eligible for Health Savings Account (HSA) and Flexible Spending Account (FSA) payment
For researchers in Thailand evaluating modern triple-agonist peptides, retatrutide is the reference compound the molecule against which newer multi-receptor analogues are benchmarked
Gradual weight loss helps reduce the risk of: Muscle loss Fatigue Nutrient deficiencies Regaining weight later Tirzepatide is designed to support steady, sustainable change rather than rapid drops on the scale
US$ 20.11
US$ 26.60
US$ 24.14
US$ 20.30
US$ 21.27
US$ 22.20
